Author

A. Gleiberman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. V. Gudkov· 2 shared A. Ashkenazi· 1 shared A. Barzel· 1 shared A. Gutwillig· 1 shared A. Iwasaki· 1 shared A. Khateeb· 1 shared A. Komissarov· 1 shared A. Osterman· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. V. Gudkov

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis

A. Gleiberman, R. Invernizzi, P. L. Molyneaux, B. G. Wu, Y. Lipinski, M. Kugler, L. N. Segal, Y. Sakamachi, E. Wiley, A. Solis, C. G. Johnson, X. Meng, J. Malphurs, B. Papas, S. Mehta, , N. Kaminski

TLR5 deficiency is linked to pulmonary fibrosis due to its role in preventing microbial dysbiosis following lung injury.

bioRxiv · Apr 30, 2024 · PreprintImmunology

Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity

Y. Carmi, L. Farhat-Younis, M. Na, A. Zarfin, N. Santana-Magal, A. Richter, A. Khateeb, A. Gutwillig, D. Rasoulouniriana, A. Gleiberman, L. Beck, T. Giger, A. Ashkenazi, A. Barzel, P. Rider

This study modifies myeloid cells to elicit tumor-specific cytotoxicity using chimeric receptors that signal through IgM and bind tumor antigens.

bioRxiv · Sep 30, 2023Immunology

Cancer relevance of circulating antibodies against LINE-1 antigens in humans

A. Vylegzhanina, I. Bespalov, K. Novototskaya-Vlasova, B. Hall, A. Gleiberman, H. Yu, O. Leontieva, K. Leonova, O. Kurnasov, A. Osterman, G. Dy, A. Komissarov, E. Vasilieva, J. Gehlhausen, A. Iwasaki, , A. V. Gudkov

The paper detects higher levels of anti-LINE-1 protein antibodies in cancer patients compared to healthy individuals, suggesting potential diagnostic value for early cancer detection.

bioRxiv · Feb 3, 2023Cancer Biology